Cohen JA, Arnold DL, DeLuca J, Hartung HP, et al. Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trials. Mult Scler 2025 Jul 23:13524585251355842. doi: 10.1177/13524585251355842.
PMID: 40698614